pharmaceutical active compounds against schizofreniesymp - restrainprocess for the preparation of pharmaceutical preparations with these compounds as the active file - part and pharmaceutical preparation to combat schizofreniesymtomen.

摘要

PRODUCT AND PROCESS Polypeptides, omega-N-acylated and/or hydrocarbon containing esters or amides of polypeptides are useful in the treatment of schizophrenia. The polypeptide-containing materials have a characteristic T-V-L structure, i.e., , (T) (V) (L) The preferred compositions are N-acytated T-V-L-containing polypeptides, especially amides.